The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Phenobarbital Oral Solution
Phenobarbital Oral · PHENOBARBITAL 30 mg/7.5mL · Solution · Oral · PAI Holdings, LLC dba PAI Pharma
NDC 00121-1884-50 · 5 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 7.5 mL in 1 CUP, UNIT-DOSE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$219.81
Reported to Texas DSHS · 2026 annual filing · PAI Holdings LLC dba Pharmaceutical Associates, Inc. / PAI Pharma
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for phenobarbital (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · label · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Phenobarbital Oral (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Kesin Pharma Corporation | PHENOBARBITAL 20 mg/5mL | Jul 15, 2026 | Sep 3, 2026 |
| Ajenat Pharmaceuticals LLC | PHENOBARBITAL 20 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| BPI Labs LLC | PHENOBARBITAL 20 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | PHENOBARBITAL 20 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | PHENOBARBITAL 30 mg/7.5mL | Jul 15, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | PHENOBARBITAL 60 mg/15mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Phenobarbital Oral Solution — NDC 00121-1884-50," retrieved September 3, 2026, https://drugdashboards.com/drug/00121188450.
Free to cite with attribution — see how the data is put together.